Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Jazz Pharmaceuticals plc - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Jazz Pharmaceuticals plc - Product Pipeline Review - 2014', provides an overview of the Jazz Pharmaceuticals plc's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Jazz Pharmaceuticals plc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Jazz Pharmaceuticals plc including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Jazz Pharmaceuticals plc's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Jazz Pharmaceuticals plc's pipeline products Reasons to buy - Evaluate Jazz Pharmaceuticals plc's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Jazz Pharmaceuticals plc in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Jazz Pharmaceuticals plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Jazz Pharmaceuticals plc and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Jazz Pharmaceuticals plc - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Jazz Pharmaceuticals plc and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Jazz Pharmaceuticals plc Snapshot 5 Jazz Pharmaceuticals plc Overview 5 Key Information 5 Key Facts 5 Jazz Pharmaceuticals plc - Research and Development Overview 6 Key Therapeutic Areas 6 Jazz Pharmaceuticals plc - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Jazz Pharmaceuticals plc - Pipeline Products Glance 12 Jazz Pharmaceuticals plc - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Jazz Pharmaceuticals plc - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Jazz Pharmaceuticals plc - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Jazz Pharmaceuticals plc - Unknown Stage Pipeline Products 16 Unknown Products/Combination Treatment Modalities 16 Jazz Pharmaceuticals plc - Drug Profiles 17 asparaginase 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 inolimomab 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 SKL-N05 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 AZP-02 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 JZP-386 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Jazz Pharmaceuticals plc - Pipeline Analysis 24 Jazz Pharmaceuticals plc - Pipeline Products by Target 24 Jazz Pharmaceuticals plc - Pipeline Products by Route of Administration 25 Jazz Pharmaceuticals plc - Pipeline Products by Molecule Type 26 Jazz Pharmaceuticals plc - Pipeline Products by Mechanism of Action 27 Jazz Pharmaceuticals plc - Recent Pipeline Updates 28 Jazz Pharmaceuticals plc - Dormant Projects 31 Jazz Pharmaceuticals plc - Discontinued Pipeline Products 32 Discontinued Pipeline Product Profiles 32 JZP-2 32 sodium oxybate 32 Jazz Pharmaceuticals plc - Company Statement 33 Jazz Pharmaceuticals plc - Locations And Subsidiaries 34 Head Office 34 Other Locations & Subsidiaries 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 36 Disclaimer 36
List of Tables Jazz Pharmaceuticals plc, Key Information 5 Jazz Pharmaceuticals plc, Key Facts 5 Jazz Pharmaceuticals plc - Pipeline by Indication, 2014 7 Jazz Pharmaceuticals plc - Pipeline by Stage of Development, 2014 8 Jazz Pharmaceuticals plc - Monotherapy Products in Pipeline, 2014 9 Jazz Pharmaceuticals plc - Partnered Products in Pipeline, 2014 10 Jazz Pharmaceuticals plc - Partnered Products/ Combination Treatment Modalities, 2014 11 Jazz Pharmaceuticals plc - Phase III, 2014 12 Jazz Pharmaceuticals plc - Phase II, 2014 13 Jazz Pharmaceuticals plc - Phase I, 2014 14 Jazz Pharmaceuticals plc - IND/CTA Filed, 2014 15 Jazz Pharmaceuticals plc - Unknown, 2014 16 Jazz Pharmaceuticals plc - Pipeline by Target, 2014 24 Jazz Pharmaceuticals plc - Pipeline by Route of Administration, 2014 25 Jazz Pharmaceuticals plc - Pipeline by Molecule Type, 2014 26 Jazz Pharmaceuticals plc - Pipeline Products by Mechanism of Action, 2014 27 Jazz Pharmaceuticals plc - Recent Pipeline Updates, 2014 28 Jazz Pharmaceuticals plc - Dormant Developmental Projects,2014 31 Jazz Pharmaceuticals plc - Discontinued Pipeline Products, 2014 32 Jazz Pharmaceuticals plc, Other Locations 34 Jazz Pharmaceuticals plc, Subsidiaries 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.